XYL
49
4
PFG
45
3
DVN
21
3
NOC
43
11
VMC
57
4
NDAQ
62
2
PSX
47
2
CPB
30
6
PAYX
53
2
VTR
47
-7
DD
63
3
RHI
59
2
HST
49
-9
PG
56
5
INTC
33
-2
ES
34
3
PEP
48
6
PSA
58
2
TROW
56
5
YUM
47
3
XYL
49
4
PFG
45
3
DVN
21
3
NOC
43
11
VMC
57
4
NDAQ
62
2
PSX
47
2
CPB
30
6
PAYX
53
2
VTR
47
-7
DD
63
3
RHI
59
2
HST
49
-9
PG
56
5
INTC
33
-2
ES
34
3
PEP
48
6
PSA
58
2
TROW
56
5
YUM
47
3
Financhill
Back

Zenas BioPharma Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
29

ZBIO
Zenas BioPharma

Last Price:
11.98
Seasonality Move:
1.54%

7 Day Trial

ALL ACCESS PASS

$ 7

Say this - unlock as much as $1,250 every Friday

Click here for full details.

Zenas BioPharma Price Quote

$11.98
-0.02 (14.75%)
(Updated: November 23, 2024 at 6:02 AM ET)

Zenas BioPharma Key Stats

Sell
29
Zenas BioPharma (ZBIO) is a Sell
Day range:
$9.45 - $12.37
52-week range:
$9.45 - $26.25
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0%
Volume:
785K
Avg. volume:
173.5K
1-year change:
0%
Market cap:
$459.8M
Revenue:
$50M
EPS:
$-1.64

How Much Does Zenas BioPharma Make?

Data Unavailable

Is Zenas BioPharma Growing As A Company?

Data Unavailable

Zenas BioPharma Stock Price Performance

  • Did Zenas BioPharma Stock Go Up Last Month?
    Zenas BioPharma share price went down by -53.27% last month
  • Did ZBIO's Share Price Rise Over The Last Year?
    ZBIO share price rose by 0% over the past 1 year

What Is Zenas BioPharma 52-Week High & Low?

Zenas BioPharma Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Zenas BioPharma?

  • How Much Debt Does Zenas BioPharma Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Zenas BioPharma Have?
    Cash and short term investments quarterly total is $183.9M
  • What Is Zenas BioPharma’s Book Value Per Share?
    Book value per share is -7.54

Is Zenas BioPharma Cash Flow Positive?

  • What Is ZBIO Cash Flow From Operations?
    Cash flow from operations (TTM) is -$33.6M
  • What Is Zenas BioPharma’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $197.2M
  • What Is Zenas BioPharma’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$74K

Zenas BioPharma Return On Invested Capital

Data Unavailable

Zenas BioPharma Earnings Date & Stock Price

Zenas BioPharma Competitors

  • Who Are Zenas BioPharma's Competitors?
    Below is a list of companies who compete with Zenas BioPharma or are related in some way:
    • Bicara Therapeutics Inc (BCAX)
    • Bioage Labs Inc (BIOA)
    • Kairos Pharma Ltd (KAPA)
    • MBX Biosciences Inc (MBX)

Zenas BioPharma Dividend Yield

Zenas BioPharma Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 46.05%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 36.75
Upside from Last Price: 206.25%

Major Shareholders

  • How many ZBIO shares are owned by institutional investors?
    23.4M ZBIO shares are owned by institutional investors
  • How many ZBIO shares are owned by insiders?
    161.2K ZBIO shares are owned by insiders